WNT7A and neoplasm: WNT7a binds to FZD9 and signals to peroxisome proliferator activated receptor gamma (PPARγ) through an Erk5-dependent cascade, leading to anti-tumor signaling, including increasing epithelial and reducing mesenchymal gene expression (3, 8).